Serious changes in Medicare reimbursement will force many women’s health providers to discontinue offering image guided breast biopsy procedures on an ongoing basis. This important procedure is the standard for diagnosing breast lesions that are suspicious.
Insufficient Medicare rates would not cover the costs of supplies and equipment needed to perform these procedures, which will limit women’s access to these procedures and lead to unnecessary operating room surgeries instead of the normal outpatient procedures. With 1.5 million breast biopsies done each year in the United States, this proposed change represents a huge threat to women’s health. If these changes are implemented, there will be increased healthcare costs, increased copays, and an increased risk for complications.
Watch as Jay K. Harness, M.D explains what this means, and what you can do to help.Whizzco